Delivery Order SPE2DB20D2104-SPE2DB22FS09N
Award Date 3/15/22
Potential Completion Date 3/16/22
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,545.13 firm fixed-price delivery order contract is for the supply of JOLESSA TABS 3X 91S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,155.72, is for a Firm Fixed Price Delivery Order to provide JOLESSA 0.15 MG-0.03 MG TABLET 91S, a type of prescription medication. The contract has an ultimate completion date of June 11, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has a ceiling value of $1,213.53 and an ultimate completion date of May 21, 2024. It is a firm fixed-price delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has a firm fixed price of $1,432.08 and a period of performance ending on May 28, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.83, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award, valued at $1,372.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The award is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,072.38, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,871.06 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is to provide the drug product JOLESSA 0.15 MG-0.03 MG TABLET 91S to DLA facilities. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the...
- This federal contract award is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The $1,250.30 firm fixed price delivery order contract has an ultimate completion date of July 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This award is not a set-aside contract, indicating open...
- This federal contract award, with the ID SPE2DB20D3103|SPE2DB22FN9H2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,213.48 firm fixed-price delivery order is for the pharmaceutical product JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor providing a...